NCT00411814View on ClinicalTrials.gov

A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Asthma

Interventions

DRUG

GSK679586

Active Drug

DRUG

Placebo

Saline

Trial Locations (2)

2031

GSK Investigational Site, Randwick

3004

GSK Investigational Site, Melbourne

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00411814 - A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers | Biotech Hunter | Biotech Hunter